The oncogenic control of nucleotide synthesis
26 March 2026 at 08:00
Oncogenesis, Published online: 26 March 2026; doi:10.1038/s41389-026-00608-2
The oncogenic control of nucleotide synthesisOncogenesis, Published online: 26 March 2026; doi:10.1038/s41389-026-00608-2
The oncogenic control of nucleotide synthesisOncogenesis, Published online: 18 March 2026; doi:10.1038/s41389-026-00610-8
Correction: LXRα limits TGFβ-dependent hepatocellular carcinoma associated fibroblast differentiationOncogenesis, Published online: 18 March 2026; doi:10.1038/s41389-026-00607-3
Teriflunomide modulates the PD-1/PD-L1 axis and enhances antitumor immunity in colorectal cancerOncogenesis, Published online: 17 March 2026; doi:10.1038/s41389-026-00609-1
IFFO1 inhibits breast cancer by coordinating mitochondrial fission and fatty acid synthesis via the LaminA/C-PGC1α axisOncogenesis, Published online: 11 March 2026; doi:10.1038/s41389-026-00605-5
Inhibition of ZBTB7B-mediated ADPGK transcription by NEDD4 impedes glycolysis and progression of lung adenocarcinomaOncogenesis, Published online: 11 March 2026; doi:10.1038/s41389-026-00604-6
14,15-epoxyeicosatrienoic acid drives intestinal adenoma growth and its value as an early biomarker for intestinal adenoma occurrenceOncogenesis, Published online: 07 March 2026; doi:10.1038/s41389-026-00606-4
C1s protects cutaneous squamous carcinoma cells from TRAIL-induced apoptosis